All vaccines utilize a risky transfection process using adjuvants
Numerous laboratory studies have confirmed the presence of plasmid DNA in Pfizer’s COVID-19 vaccines. In fact, a recent analysis reveals that a single dose of the Pfizer vaccine can contain over 200 billion DNA fragments. These are nucleotides that should never enter the human supply chain because they can cause cancer.
Plasmids, which are used in the manufacturing process for vaccines, carry genetic material that can inadvertently enter the human body through vaccination. Plasmids can disrupt cellular functions or contribute to the development of antibiotic resistance. These fragments have the potential to integrate into the DNA of vaccinated individuals, potentially disrupting the function of oncogenes and tumor suppressor genes. One troubling aspect is the inclusion of sequences from the SV40 virus, known for its cancer-causing properties. The implications of such contamination are dire, with experts warning of the potential for permanent genetic changes in vaccine recipients.
This serious safety concern necessitates that ALL recombinant vaccines be investigated for DNA contamination. The current findings on DNA contamination across the vaccine supply are startling, and warrant an audit into the manufacturing processes of vaccines, including investigations into the role adjuvants and lipid nanoparticles play in facilitating the DNA contamination of human cells.